Role of immunological cells in hepatocellular carcinoma disease and associated pathways
R Aasarey, K Yadav, BK Kashyap… - ACS Pharmacology & …, 2023 - ACS Publications
Hepatocellular carcinoma (HCC) remains one of the predominant causes of cancer-related
mortality across the globe. It is attributed to obesity, excessive alcohol consumption …
mortality across the globe. It is attributed to obesity, excessive alcohol consumption …
Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis
Y Guo, Y Ren, L Zhu, L Yang, C Zheng - Scientific reports, 2023 - nature.com
Although numerous studies have reported the association between sarcopenia and the
prognosis of hepatocellular carcinoma (HCC) patients, there is lack of a newer and more …
prognosis of hepatocellular carcinoma (HCC) patients, there is lack of a newer and more …
circGFRA1: a circular RNA with important roles in human carcinogenesis
Circular RNAs (circRNAs) are a type of covalently closed RNA molecules, which are mainly
formed by back splicing of a precursor mRNA upstream exon into a downstream exon …
formed by back splicing of a precursor mRNA upstream exon into a downstream exon …
Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study
Current guidelines recommend hepatocellular carcinoma (HCC) surveillance for at-risk
individuals, including individuals with hepatitis B virus infection. However, the performance …
individuals, including individuals with hepatitis B virus infection. However, the performance …
N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes
Y Wei, J Fu, H Zhang, Y Ling, X Tang, S Liu, M Yu… - Iscience, 2023 - cell.com
CircRNAs play multiple roles in a variety of cellular processes. We found that Circ-CDYL is
highly enriched in early HCC plasma exosomes. Moreover, EpCAM+ HCC cells and …
highly enriched in early HCC plasma exosomes. Moreover, EpCAM+ HCC cells and …
Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma
Z Wang, P Gao, W Sun, A Rehman, J Jiang… - Frontiers in …, 2023 - frontiersin.org
Background Hepatocellular carcinoma (HCC) is one of the most frequent malignancies.
Alpha-fetoprotein (AFP) has some limitations in diagnosing early HCC. Recently, long …
Alpha-fetoprotein (AFP) has some limitations in diagnosing early HCC. Recently, long …
Resource-appropriate evidence-based strategies to improve breast cancer outcomes in low-and middle-income countries guided by the Breast Health Global Initiative …
BO Anderson, C Duggan… - Journal of surgical …, 2023 - pubmed.ncbi.nlm.nih.gov
Keywords: Breast Health Global Initiative (BHGI); Global Breast Cancer Initiative (GBCI)
framework; breast cancer early detection; breast cancer patient pathway; cancer diagnosis; …
framework; breast cancer early detection; breast cancer patient pathway; cancer diagnosis; …
[HTML][HTML] S3-Leitlinie Diagnostik und Therapie biliärer Karzinome–Langversion
M Bitzer, S Groß, J Albert… - Zeitschrift für …, 2023 - thieme-connect.com
In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …
Stereotactic body radiation therapy versus radiofrequency ablation in hepatocellular carcinoma: an up-date meta-analysis
D Yang, K Lin, Y Wang, X Xie, X Xie, B Zhuang - Abdominal Radiology, 2023 - Springer
Purpose Radiofrequency ablation (RFA) and stereotactic body radiotherapy (SBRT) are
available locoregional curative treatments for nonsurgical Hepatocellular carcinoma (HCC) …
available locoregional curative treatments for nonsurgical Hepatocellular carcinoma (HCC) …
[PDF][PDF] Resposta objetiva tumoral e taxas de sobrevida de pacientes com cirrose e carcinoma hepatocelular submetidos à radioembolização com ¹³¹I-lipiodol versus …
MCO Ribeiro - 2023 - repositorio.unesp.br
Introdução: O carcinoma hepatocelular (CHC) ocorre principalmente em portadores de
cirrose e seu tratamento envolve terapias como a quimioembolização transarterial (TACE) …
cirrose e seu tratamento envolve terapias como a quimioembolização transarterial (TACE) …